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Abstract
Adolescent idiopathic scoliosis (AIS) is a complex three-dimensional deformity of the spine. The cause and pathogenesis of
scoliosis and the accompanying generalized osteopenia remain unclear despite decades of extensive research. In this study,
we utilized two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) coupled with mass spectrometry (MS) to
analyze the differential proteome of bone marrow mesenchymal stem cells (BM-MSCs) from AIS patients. In total, 41
significantly altered protein spots were detected, of which 34 spots were identified by MALDI-TOF/TOF analysis and found
to represent 25 distinct gene products. Among these proteins, five related to bone growth and development, including
pyruvate kinase M2, annexin A2, heat shock 27 kDa protein, c-actin, and b-actin, were found to be dysregulated and
therefore selected for further validation by Western blot analysis. At the protein level, our results supported the previous
hypothesis that decreased osteogenic differentiation ability of MSCs is one of the mechanisms leading to osteopenia in AIS.
In summary, we analyzed the differential BM-MSCs proteome of AIS patients for the first time, which may help to elucidate
the underlying molecular mechanisms of bone loss in AIS and also increase understanding of the etiology and pathogenesis
of AIS.
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Introduction
Adolescent idiopathic scoliosis (AIS) is a complex three-
dimensional deformity of the spine occurring mostly in girls
between 10 and 16 years of age during the pubertal growth spurt.
The general incidence of AIS has been reported to range from
2.0% to 4.0% [1–3]. In Hong Kong, for instance, the prevalence
rate of AIS increased from 2.7% in 1998 to 4.0% in 2003 among
school children [4]. If untreated, severe scoliotic deformity
affecting the thoracic region can progress, impairing cardiopul-
monary function, thereby increasing the mortality rate [5,6].
The main treatment of AIS includes full-time bracing [7], which
may cause back pain along with psychological disorder, and
pedical screw instrumentation, which inevitably leads to major
operative trauma, decreased spinal range of motion [8], and even
permanent catastrophic neurologic or vascular injury in case of
screw malposition [9]. With the ultimate hope of developing more
specific treatments and avoiding the above risks, extensive studies
are carried out from different aspects, including histological,
immunofluorescent, genetic and molecular biological studies of
blood and tissue specimens from different animal models and AIS
patients, as well as the imaging, cognitive, endocrinological, and
neurological researches in AIS paitents [10–16]. However, no
single factor can explain the whole clinical picture of AIS, and the
pathogenesis remains largely unknown [17,18].
The low bone mineral density (BMD) in AIS reported by many
authors suggested the possibility of bone metabolism disturbance
[19–25]. Moreover, a bone biopsy study reported diminished
number of osteoblasts and a corresponding reduction in osteoclast
number in patients with AIS [26], indicating disturbance in the
bone metabolism as a primary change. In spite of the presence of
much controversy engendered by all the hypotheses and
considerable gaps in the related knowledge, there is a growing
consensus that anomalies of bone growth and development are
strongly related to the onset and progression of scoliosis.
Mesenchymal stem cells (MSCs) are well known for playing a
pivotal role in bone growth, bone modeling, and bone remodeling.
MSCs are able to act as a source of progenitors for osteoblasts, and
also regulate osteoclastogenesis via their expression of RANKL
and OPG [27–31]. Furthermore, MSCs are indispensable in both
intramembranous and endochondral bone formation. Intramem-
branous bone formation requires periosteal MSCs to undergo
osteogenic differentiation and form bone without a preceding
cartilage step. Endochondral bone formation, running alongside
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18834the intramembranous process, begins with the differentiation of
condensed MSCs into chondroprogenitors and osteoprogenitors,
both of which will undergo coupled proliferation and differenti-
ation programs and ultimately form mature cartilage and bone
[27].
Given the functional characteristics of MSCs in bone formation
and resorption, it is very likely that MSCs play a significant role in
the etiology and pathogenesis of AIS. A recent study, which
supports our speculation, observed lower osteogenic differentiation
abilities and alkaline phosphatase activities of MSCs from AIS
patients [32], indicating that the decreased osteogenic differenti-
ation ability of MSCs might be a possible mechanism leading to
low bone mass in AIS. However, to the best of the authors’
knowledge, there have been virtually no reports on the proteomics
of MSCs from AIS patients in the literature up to this point.
Therefore, to gain an insight into the pathogenesis of AIS, we
studied specific alterations in the proteome of MSCs by using two-
dimensional fluorescence difference gel electrophoresis (2D-
DIGE)and mass spectrometry (MS). This study focused on
depicting the differential proteome of bone marrow mesenchymal
stem cells (BM-MSCs) from AIS patients, by comparing the MSCs
proteomic profile of AIS patients with that of lower-leg fractured
non-AIS patients.
Methods
Patients and Specimens
Bone marrow (BM) aspirates were obtained from six AIS
patients (mean age 12.3 years, range 11–14) and six non-AIS
patients with lower-leg fracture (mean age 12.6 years, range 11–
14). In the AIS group, all of the patients underwent full clinical
and radiological examinations to rule out other causes of scoliosis
and to ascertain the diagnosis of AIS. The subject exclusion
criteria were scoliosis of congenital, neuromuscular, or metabolic
etiology, skeletal dysplasia, known endocrine and connective tissue
abnormalities, and mental retardation. In the control group, each
of the six age- and gender- matched subjects with no history of
spinal disease had a straight spine and a normal forward bending
test on the physical examination. They were confirmed to be free
of any associated medical diseases, spinal deformities, or
neurological problems when entered to the study. The study was
approved by the Ethics Committee of Chinese Academy of
Medical Sciences and Peking Union Medical College Hospital.
Written informed consent was obtained from all subjects and their
parents before entering the study.
Isolation and Culture of Cells from Human Bone Marrow
Mononuclear cells were separated by Ficoll gradient centrifu-
gation (density 1.077 g/cm
3) and depleted of hematopoietic cells
using MACS CD45, GlyA, and CD34 micromagnetic beads
(Miltenyi Biotec, Inc., Auburn, CA, USA) [33,34]. The cells were
washed twice and plated in T-75 tissue culture flasks at a density of
1610
6/ml. Expansion medium contained 57% DMEM/F-12
(Gibco Life Technologies, Paisley, UK), 40% MCDB-201 (Sigma,
St.Louis, MO, USA), 2% fetal calf serum (FCS; Gibco), 16insulin
transferrin selenium (ITS; Gibco), 10
28 M dexamethasone
(Sigma), 10
24 M ascorbic acid 2-phosphate (Sigma), 10 ng/ml
epidermal growth factor (EGF; Sigma), 10 ng/ml platelet-derived
growth factor BB (PDGF-BB; Sigma), 100 U/ml penicillin, and
100 mg/ml streptomycin (Gibco). Once adherent cells were more
than 70% confluent, they were detached with 0.125% trypsin and
0.01% EDTA, and replated at a 1:3 dilution under the same
culture conditions. Confluent cells (approximately 2610
6) at the
third passage were used for the experiments.
Immunophenotype Analysis
For immunophenotype analysis of BM-MSCs, the cells were
detached and washed with phosphate buffered saline (PBS)
containing 0.5% bovine serum albumin (BSA; Sigma), and
incubated with primary antibodies for 30 min at 4uC. Working
concentrations for primary antibodies against human CD29,
CD31, CD34, CD44, CD45, CD73, and CD105, (BD Biosciences)
were 10 ng/ml. We used same-species, same-isotype irrelevant
antibody as the negative control. After washing with PBS
containing 0.5% BSA, the cells were incubated with fluorescein
isothiocyanate (FITC)-conjugated secondary antibodies for 30 min
at 4uC. After three washes, cells were resuspended in PBS and
analyzed by flow cytometry with a FACSCalibur flow cytometer.
Each measurement contained 10000 events.
Osteogenic and Adipogenic Differentiation
To identify the MSC capacity for multilineage differentiation,
MSCs were cultured under differentiation conditions.
The culture-expanded cells at a density of 2610
4/cm
2 were
induced in the following osteogenic medium for 2–3 weeks:
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% FCS, 10 mmol/L b-glycerophosphate, 10
28 mol/L dexa-
methasone, and 0.2 mmol/L ascorbic acid (all from Sigma). Cells
were then stained with the alkaline phosphatase (ALP) staining kit
(Beyotime, China) to reveal osteogenic differentiation.
To test the adipogenic differentiation ability, the culture-
expanded cells at a density of 2610
4/cm
2 were induced for 3
weeks in DMEM supplemented with 10% FCS, 0.5 mmol/L
hydrocortisone, 0.5 mmmol/L isobutylmethylxanthine, and
50 mg/ml indomethacin (all from Sigma). At the end of the
culture, the cells were fixed in 10% formalin for 10 min and
stained with fresh Oil red-O solution (Sigma) to show lipid droplets
in induced cells.
Protein Sample Preparation
Cell pellets were dissolved in lysis buffer (7 M urea, 2 M
thiourea, 4% CHAPS, 10 mM Tris). For improved cell lysis, the
solution was sonicated on ice for 1 min with 1 s pulse-on and 1 s
pulse-off to prevent overheating. After incubation for 30 min at
room temperature with repeated vortexing, the samples were
centrifuged at 400006g for 60 min at 10uC to remove unbroken
cells from the homogenate. The supernatant was stored in aliquots
at 280uC. Protein concentration was determined with the
Bradford assay kit (BioRad) using albumin diluted in lysis buffer
as the standard.
DIGE Labeling and Two-Dimensional(2D) Electrophoresis
Cell lysates were labeled with Cy2, Cy3, and Cy5 following
the protocols described in the Ettan DIGE User Manual (18-
1164-40 Edition AA, GE Healthcare). The DIGE experimental
design is shown in Table 1. Typically, 50 mg of lysates (25 mg62)
were labeled with 400 pmol of Cy3 or Cy5, while the same
amount of the pool standard containing equal amounts of all
samples were labeled with Cy2. Labeling was carried out in the
dark on ice for 30 min. Reactions were then quenched by the
addition of 1 mL of 10 mM lysine for 10 min on ice. After
labeling and quenching, differentially labeled samples were
mixed with the pooled Cy2-labeled extracts, and an equal
volume of 26 sample buffer (7 M urea, 2 M thiourea, 4%
CHAPS, 2% Bio-Lyte, pH 3–10 nonlinear, 2% dithiothreitol)
was added to the sample, then the total volume was made up to
450 ml with rehydration buffer (7 M urea, 2 M thiourea, 4%
CHAPS, 20 mM DTT, 1% Biolyte).
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previously described with some modifications [35]. IPG strips
(24 cm, pH 3–10 nonlinear, GE) and Ettan IPGphor System
(GE Healthcare) were used for the first-dimension IEF under the
following conditions: 30 V, rapid, 6 h; 60 V, rapid, 6 h; 200 V,
rapid, 1 h; 500 V, rapid, 1 h; 1000 V, 1 h, 1000–10000 V,
linear, 3 h; and 10000 V, rapid, 60000 Vh. The strips were then
treated with a two-step reduction and alkylation step prior to the
second-dimension SDS-PAGE. After equilibration with a
solution containing 6 M urea, 2% sodium dodecyl sulfate
(SDS), 30% glycerol, 50 mM Tris-Cl (pH 8.8), and 0.5% w/v
dithiothreitol (DTT) for 15 min at room temperature, the IPG
strips were treated with the same solution containing 4.5% w/v
iodoacetamide instead of DTT for another 15-min incubation at
room temperature. For the second-dimension SDS-PAGE, the
strips were overlaid onto 12% polyacrylamide gels (20624 cm),
immobilized to a low-fluorescent glass plate and electrophoresed
for 1 h at 10 mA and then for approximately 15 h at 20 mA per
gel using an Ettan DALT Six (GE Healthcare). After 2-DE, gels
were scanned on the Typhoon 9410 scanner (GE Healthcare)
with Ettan DALT gel alignment guides using excitation/emission
wavelengths specific for Cy2 (488/520 nm), Cy3 (532/580 nm),
and Cy5 (633/670 nm). The intensity was adjusted to ensure
that the maximum volume of each image was between 60,000
and 90,000.
Image Acquisition and Analysis
DeCyder v.6.5 was used to analyze the DIGE images as
described in the Ettan DIGE User Manual (GE Healthcare). A
DeCyder differential in-gel analysis (DIA) module was performed
for image analysis between samples within the same gel, while a
DeCyder biological variation analysis (BVA) module was
performed for pairwise image analysis among multiple gels.
Briefly, in DIA, the Cy2, Cy3, and Cy5 images for each gel were
merged, spot boundaries were automatically detected, and
normalized spot volumes ( protein abundance) were calculated.
The resulting spot maps were exported to BVA. The best internal
standard image was assigned as the ‘‘Master,’’ which was used as
a template. The protein spots on the remaining internal standard
images were all matched to the master gel to ensure that the same
protein spots were compared between gels. Matching of the
protein spots across all gels was performed after several rounds of
extensive land marking and automatic matching. The match was
then checked manually to ascertain the accuracy of the match
process. Dividing each Cy3 or Cy5 spot volume with the
corresponding Cy2 (internal standard) spot volume within each
gel gave a standard abundance, thereby correcting integral
variations.
The Student’s t test was used for statistical analysis of the
data. Protein spots that were differentially expressed between the
AIS and control groups (|ratio|$1.3, p#0.05) were marked.
Only spots altered consistently in all gels were selected for
identification.
Spot Excision and In-gel Tryptic Digestion
Separate preparative gels were run to obtain sufficient amounts
of protein for MS analysis. These gels were fixed and stained with
colloidal Coomassie Brilliant Blue (cCBB; Amresco) [36]. Proteins
of interest, as defined by the 2D-DIGE/DeCyder analysis, were
excised from the cCBB-stained gels for a modified in-gel tryptic
digestion procedure. Gel pieces were first destained with 50%
ACN and 25 mM of ammonium bicarbonate. Following vacuum
drying, the gel pieces were incubated with sequencing-grade
modified trypsin (Promega) at a final concentration of 0.01 mg/
mL in 25 mM of ammonium bicarbonate (Fluka) or 16 h at 37uC.
Then the tryptic peptides were extracted from the gels with 5%
TFA at 40uC. After extraction for 30 min, the gels underwent
sonication for 3 min with an ultrasonic processor and then another
30 minutes’ extraction. After collecting the supernatants, the gels
were treated with 2.5% TFA, 50% ACN at 30uC for half an hour,
then sonicated for 3 min and subsequently treated with the same
solution for another half an hour. The extracts were pooled,
vacuum-dried, and redissolved in 0.1% TFA for MS analysis.
MALDI-TOF/TOF Analysis
A total of 0.8 ml peptides were spotted on to the 384-well
stainless steel MALDI target plates and dried, followed by 0.6 ml
MALDI matrix (7 mg/mL CHCA and 0.1% TFA and 50% ACN)
spotted on the same point. Samples on the MALDI target plates
were then analyzed using an ABI 4800 Proteomics Analyzer
MALDI-TOF/TOF mass spectrometer (Applied Biosystems). For
MS analyses, typically 1000 shots were accumulated for each spot,
while for MS/MS analysis, 2000 shots were accumulated. MS/MS
analyses were performed using air, at collision energy of 2 kV.
MASCOT search engine (version 2.1, Matrix Science) was used to
search all of the tandem mass spectra. GPS Explorer
TM software
version 3.6.2 (Applied Biosystems) was used to create and search
files with the MASCOT search for peptide and protein
identification. The IPI human database v3.53 (http://www.ebi.
ac.uk/IP/IPIhelp.html) was used for the search and was restricted
to tryptic peptides. Searches were performed to allow for
carbamidomethylation, oxidation, and a maximum of one missed
trypsin cleavage. Precursor error tolerance was set to ,0.2 Da and
MS/MS fragment error tolerance ,0.3 Da. The confident
identification had a statistically significant (p#0.05) protein score
(based on combined mass and mass/mass spectra) and best ion
score (based on mass/mass spectra). Proteins that appeared in the
database under different names and accession numbers were
eliminated. If more than one protein was identified in one spot, the
single protein member with the highest protein score (top rank)
was singled out from the multiprotein family.
Western Blot Analysis
Five differentially expressed proteins of the 25 identified
proteins, pyruvate kinase M2 (PKM2), annexin A2, heat shock
27 kDa protein (HSP27), c-actin and b-actin were further
validated by Western blot analysis, using ubiquitous housekeeping
protein GAPDH as the loading control.
Samples were run on 12% SDS-polyacrylamide gels and
transferred onto nitrocellulose (NC; GE) membranes in a trans-
Table 1. DIGE experimental design for samples from AIS
group and control group.
a
Gel Cy2 Cy3 Cy5
01 Pool of (A 1–6+C1–6) (50 mg) C1+C2
(25 mg each)
A1+A2
b
(25 mg each)
02 Pool of (A 1–6+C1–6) (50 mg) A3+A4
(25 mg each)
C3+C4
(25 mg each)
03 Pool of (A 1–6+C1–6) (50 mg) C5+C6
(25 mg each)
A5+A6
(25 mg each)
a) A total of 150 mg of labeled proteins were loaded on each gel for 2D
electrophoresis.
b) 6 samples from AIS group and 6 samples from control group were randomly
numbered as A1,A6 and C1,C6, respectively.
doi:10.1371/journal.pone.0018834.t001
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blocked for 1 h at room temperature in 20 mM Tris-HCl,
140 mM NaCl, pH 7.5, 0.05% Tween-20 (TBST) containing
5% skim milk. The primary antibodies used were anti-glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) mouse monoclonal
antibody (diluted 1:2000, ProteinTech), anti-b-actin mouse
monoclonal antibody (diluted 1:1000, ProteinTech), anti-c-actin
mouse monoclonal antibody (diluted 1:1000, Sigma), purified anti-
annexin A2 mouse monoclonal antibody (diluted 1:500, BD), anti-
HSP27 mouse monoclonal antibody (diluted 1:1000, Cell Signal
Technology), and anti-PKM2 rabbit polyclonal antibody (diluted
1:1000, Cell Signaling Technology). After washing five times with
TBST, 3 min each time, membranes were incubated with each
primary antibody at room temperature for 2 h. Blots were then
washed for additional five times with TBST and incubated with
corresponding rabbit anti-mouse or goat anti-rabbit peroxidase-
conjugated secondary antibody (diluted 1:10000, Zhongshan
Goldenbridge Technology) for 1 h at room temperature. After
washing five times with TBST, immunoreactive complexes were
visualized using ECL reagents (Supersignal West Pico Chemilu-
minescent Substrate, Thermo). All of the membranes were
exposed on the same X-ray film and scanned by Image Scanner
(UMAX, Amersham Biosciences). A semiquantitative analysis
based on OD was performed by QuantitiOne software (Bio-Rad).
Results
The Biological Characteristics of MSCs
All of the cultured cells from AIS patients and non-AIS patients
with lower-leg fracture grew well and displayed fibroblast-like
morphology in culture medium when observed under a light
microscope. To demonstrate that these isolated cells were MSCs,
we investigated their immunophenotypes coupled with multi-
lineage differentiation capacities. These cells from both the AIS
and control groups were persistently negative for CD31, CD34,
and CD45, but expressed high levels of CD29, CD44, CD73, and
CD105 (Figure 1). Furthermore, they can be differentiated into
osteoblasts and adipocytes, which was verified by ALP and Oil
Red O staining (Figure 2).
Identification of Proteins Using 2-DE
We analyzed the MSC proteome of a group of 12 individuals
(six AIS patients and six non-AIS controls) by 2D-DIGE. Globally,
1658637 spots (mean 6 SD; n=6, AIS; n=6, non-AIS controls)
were detected on each analytical gel loaded with 50 mg of total
protein lysate per sample type (AIS or control).
As for the analyzed gel spots, we selected those fulfilling two
criteria: expression change of at least 1.3-fold compared to the
control group and a significant t test result (n=6 in each group,
p,0.05). The comparison between MSCs from AIS and control
groups resulted in the identification of 41 significantly different
spots, the locations of which on the 2D gels were labeled with spot
ID (Figure 3). These spots were excised manually from silver-
stained gels and were identified by MS. A total of 34 spots of the
41 excised (82.9%), representing 25 different gene products, were
unambiguously identified as either up-regulated or down-regulat-
ed. The mass spectra of five significantly differential proteins
related to bone metabolism, including PKM2, annexin A2, , b-
actin, c-actin, and HSP27, are presented in Figure S1, S2, S3, S4,
S5, respectively.
Table 2 provides a list of identified proteins with their respective
spot ID, protein name, IPI ID, the theoretical pI/MW, the
percentage of sequence coverage, p-value, total protein score, best
ion score, and peptide sequence determined by MS. Five of these
25 identified proteins were found in more than one spot, according
to similar molecular masses and pIs: UDP-glucose dehydrogenase
(IPI 00031420) was found in spots 9 and 10; ATP synthase subunit
a, mitochondrial (IPI 00440493) in spots 13, 14, and 16; c-actin
(IPI 00021440) in spots 21, 22, 23, 24, and 25; b-actin (IPI
00894365) in spots 26 and 27, and annexin A2 (IPI 00455315) in
spots 29 and 32.
Functional Classification and Subcellular Location of
Identified Proteins
The proteins listed in Table 2 were classified into different
groups according to their biological process, molecular function,
and cellular component using the GOFACT program (http://61.
50.138.118/gofact) based on Gene Ontology (GO) terms [37].
The majority of proteins that changed at least 1.3-fold (with
p,0.05) were involved in cellular metabolic (57.1%), biological
regulation (38.1%), and biosynthetic processes (23.8%) (Figure 4A).
Furthermore, an analysis of subcellular distribution of the
differential proteins allowed the differentiation of 9 different
categories (Figure 4B). The majority of proteins were located in the
following five subcellular positions: cytoplasm (66.7%), cytoskele-
ton (23.8%), membrane (19%), mitochondrion (19%), and nucleus
(19%), while the remaining reside in the vesicle, extracellular
region, ribonucleoprotein complex, and endoplasmic reticulum.
Interestingly, five of twenty-five differentially expressed proteins
(b-actin, c-actin, HSP27, WD repeat-containing protein 1, and
moesin) were localized in the cytoskeleton, all of which were down-
regulated in our experiment. Additionally, the classification of the
gene products based on their molecular function resulted in 8
different categories (Figure 4C), among which the binding function
represents the largest group (90.5%). The proteins were classified
into the following categories: binding, catalytic activity, hydrolase
activity, enzyme regulator activity, transport, signal transducer
activity, structural molecule activity, and transcription regulator
activity.
Protein Validation by Western Blot
Significantly differential proteins that were most likely to have
biological importance, including PKM2, annexin A2, HSP27, c-
actin, and b-actin, were detected by Western blot analysis for their
expression. The results are displayed in Figure 5. The expression
of b-actin, HSP27, c-actin, and annexin A2 was down-regulated,
and that of PKM2 was up-regulated in the AIS group. All of these
change patterns of the selected proteins were in agreement with 2-
DE results. Therefore, the results of Western blot analysis
confirmed the reliability of the proteomic analysis.
Discussion
The etiology and pathophysiologic process underlying AIS
remains unclear despite the number of studies performed. Current
views maintain that AIS is a multifactorial disease involving
genetic [10,38], skeletal [39,40], environmental [41–43], bio-
chemical [13], and neurohormonal factors [14–16].
It is generally recognized that abnormal growth is associated
with the development and progression of the scoliotic curves [44–
45]. Furthermore, persistent general osteopenia of AIS patients
indicates imbalance between bone resorption and bone formation
in AIS [19–25]. Interestingly, recent findings [26,32] of dimin-
ished numbers of osteoblast and lower osteogenic differentiation
abilities of MSCs from AIS patients rendered the MSCs
impairment one possible mechanism of osteopenia in AIS, which
has aroused growing concern.
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AIS, together with functional characteristics of MSCs, strongly
suggest that MSCs may play a significant role in the etiology and
pathogenesis of AIS. However, due to the lack of research in this
area, we know very little of the biological characteristics,
proteomic alterations, and the possible role of MSCs in the
pathogenesis of AIS and accompanying generalized osteopenia.
Therefore, to investigate the molecular mechanism of decreased
osteogenic differentiation ability of MSCs and gain an insight into
the pathogenesis of AIS, we employed 2D-DIGE and MS-based
proteomic approaches to explore the differential protein expres-
sion patterns in MSCs of AIS and non-AIS controls. To the best of
our knowledge, this study is the first research on AIS in the field of
proteomics, and also one of only a few studies focused on MSCs
from AIS patients.
As previously described, 41 spots were revealed with at least 1.3-
fold changes in expression and 25 differentially expressed proteins
were successfully identified by MALDI-TOF/TOF-MS. Due to
their significant expression alterations as well as potential
functional relevance to bone growth and development, five of
these proteins, including PKM2, annexin A2, HSP27, c-actin, and
b-actin, were chosen to be further validated by Western blot
analysis. These five differential proteins will be discussed in the
following section.
PKM2
It is well known that different isoenzymes of pyruvate kinase are
expressed depending on the metabolic responsibilities of the
various cells and tissues. Among them, pyruvate kinase isoenzyme
type M2 (PKM2, M2-PK) is characteristic of cells with high rates
of nucleic acid synthesis, including most of the proliferating cells,
such as adult stem cells, embryonic cells, and tumor cells [46,47].
According to previous reports, PKM2 plays an important role in
both cell proliferation and differentiation. In tumor cells, PKM2
has been regarded as an important metabolic sensor to adapt
tumor metabolism to varying nutrient and oxygen supply
conditions, thus facilitating cell proliferation and survival [48]. It
was also observed in the BB13 cell line that PKM2 translocated to
the nucleus by IL-3 enhanced EGF-induced proliferation [49]. In
addition, using NIH3T3 cell line, Gilles A’s finding suggested that
PKM2 could regulate cell proliferation, cell growth and apoptosis
in a glucose supply-dependent manner [50].
Figure 1. The immunophenotypes of MSCs from control and AIS groups. The figure shows immunophenotypes of MSCs isolated from non-
AIS patients with lower-leg fracture (control) and AIS patient detected by FACS.
doi:10.1371/journal.pone.0018834.g001
Differential Proteome Analysis of AIS BM-MSCs
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e18834More importantly, inhibition of PKM2 induces a significant
decrease in the population doubling (PDL) and cell proliferation
rates, as well as an increase in cell size [50]. Contrary to this,
overexpression of PKM2 was found to enhance cell proliferation
in the absence of interleukin-3 [49]. All of these studies suggest
that PKM2 plays an important role in cell proliferation.
Furthermore, it has been reported that PKM2 is able to
stimulate Oct-4-mediated transcriptional activation. Oct-4, as a
central mediator of the undifferentiated pluripotent state of
embryonic stem cells, may prevent expression of genes activated
during differentiation [51]. These observations indicate that
PKM2 could negatively regulate cell differentiation through
modulating the transactivation potential of the Oct-4 transcription
factor.
In our study, PKM2 was significantly up-regulated in the MSCs
of AIS, suggesting that the proliferation ability of MSCs in AIS
might be increased. In contrast to our speculation, Park et al found
the proliferation rate of MSCs obtained from AIS patients to be
similar to that of the control subjects [32]. However, the author
also states that the number of patients included in their study was
relatively small and suggests performing larger studies. Therefore,
the exact alteration of MSC proliferation ability in AIS needs
further large-scale studies to clarify.
Additionally, due to the negative correlation between PKM2
and cell differentiation, up-regulation of PKM2 in the AIS-MSCs
in our experiment indicates decreased differentiation ability of
MSCs in AIS, which not only support previous observation of
reduction of osteogenic differentiation ability of AIS-MSCs, but
also provide a possible mechanism of persistent general osteopenia
of AIS patients.
Annexin A2
In this study, annexin A2 was differentially down-regulated in
MSCs obtained from AIS patients. These molecules belong to the
annexin protein family, which have in common that they bind to
acidic phospholipids in the presence of calcium [52–55]. Annexin
A2 contains four 70–80 amino acid repeats with an annexin
consensus sequence. These four repeats form the conserved core
region, which is responsible for the Ca
2+-dependent binding of the
proteins to phospholipids [56].
Annexin A2, which is highly expressed by osteoblasts [57],
osteoarthritic chondrocytes [58,59], hypertrophic and terminally
differentiated growth plate chondrocytes [60], has been demon-
strated to play a significant role in both intramembrane and
intrachondral ossification.
Figure 2. Cell morphology, osteogenic and adipogenic differentiation abilities of MSCs from control and AIS groups. (A) Cell
morphology of MSCs of the control and AIS groups at the 3rd passage (Magnification 1006). (B) Oil red O staining of MSCs of the control and AIS
groups after adipogenic induction for two weeks (Magnification, 2006). (C) ALP staining of MSCs of the control and AIS groups after osteogenic
induction for two weeks (Magnification, 2006).
doi:10.1371/journal.pone.0018834.g002
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PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e18834In growth plate chondrocytes, it has been found that annexin
A2 is essential to form Ca
2+ channels in both the plasma
membrane [56] and matrix vesicles [61], which are particles
released from the plasma membrane of mineralizing cells, and
thereby initiating the mineralization process. The annexin-
mediated alteration in Ca
2+ homeostasis thereby regulates a
whole sequence of events eventually leading to matrix minerali-
zation. Furthermore, it has also been reported that inhibiting
annexin channel function prevents terminal differentiation and the
mineralization of growth plate chondrocytes in vitro [60].
Similarly, human osteoarthritic chondrocytes also release
annexin A2-containing matrix vesicles, which initiate mineral
formation [57]. Annexin A2, which is not detectable in the upper,
middle, and deep zones of healthy human articular cartilage, is
expressed by chondrocytes in the upper zone of early- and late-
staged human osteoarthritic cartilage [57].
Annexin A2 has also been shown to play an important role in
the mineralization of osteoblastic cells. It was found that
overexpression of annexin A2 led to increased ALP activity,
which would be further elevated following differentiation [62].
Figure 3. Identification of the differentially expressed proteins using 2-DE. The figure displays Representative 2D-DIGE images of MSCs
labeled with Cy3(B) , Cy5(C),Cy2(D) and overlay of the three color images(A) derived from a single gel. Spots for which the quantitative statistical
analysis revealed .1.3-fold protein expression change and a Student’s t test p value less than 0.05 in the AIS group were annotated by numbers
according to pI and Mw. The annotated protein spots were cut out of the gel and subjected to tryptic digestion followed by MS analysis.
doi:10.1371/journal.pone.0018834.g003
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PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18834Table 2. Differentially expressed proteins identified in MSCs from AIS group and Control group by 2-DE and MS or MS/MS
a).
Spot
No.
b)
Protein
description
c) IPI No
d) MW
e) PI
f)
Sequence
coverage
g) P value
Average
Ratio
h)
Total
protein
Score
i)
No.of
matched
peptide
(MS)
j) Peptides sequence
k)
3 Moesin IPI00872814 67644.8 6.09 25% 0.026 21.4 99 16 APDFVFYAPR(48)
4 Glycyl-tRNA
synthetase
IPI00783097 83086.6 6.61 18% 0.006 21.35 131 12 LPFAAAQIGNSFR(50)
TLYVEEVVPNVIEPSFGL(43)
5 Heat shock
70 kDa protein 9
IPI00007765 73634.8 5.87 25% 0.026 21.51 258 14 LLGQFTLIGIPPAPR(49)
AQFEGIVTDLIR(43)
VQQTVQDLFGR(40)
6 WD repeat-
containing
protein 1
IPI00746165 66151.9 6.17 23% 0.0082 21.34 97 15 VFASLPQVER(28)
7 FK506 binding
protein 10
IPI00334818 51992.1 5.23 22% 0.0076 1.31 114 11 NTLVAIVVGVGR(38)
8 T-complex protein
1 subunit alpha
IPI00290566 60305.6 5.8 20% 0.012 21.34 140 10 EQLAIAEFAR(38)
9 UDP-glucose
dehydrogenase
IPI00031420 54989.2 6.73 42% 0.0039 21.44 238 13 RIPYAPSGEIPK(45)
VLIGGDETPEGQR(41)
LAANAFLAQR(38)
10 UDP-glucose
dehydrogenase
IPI00031420 54989.2 6.73 35% 0.02 21.39 234 15 EQIVVDLSHPGVSEDDQVSR(56)
LAANAFLAQR(47)
11 Glucose-6-
phosp-hate
1-dehydrogenase
IPI00289800 59219 6.39 26% 0.0029 1.34 288 17 LSNHISSLFR(48) IIVEKPFGR(38)
12 Tubulin, beta IPI00645452 47736 4.7 25% 0.019 1.49 235 11 FPGQLNADLR(56) YLTVAAVFR(48)
GHYTEGAELVDSVLDVVR(41)
13 ATP synthase
subunit alpha,
mitochondrial
IPI00440493 59713.6 9.16 26% 1.00E-05 1.35 170 11 TGAIVDVPVGEELLGR(66)
EAYPGDVFYLHSR(47)
14 ATP synthase
subunit alpha,
mitochondrial
IPI00440493 59713.6 9.16 31% 0.046 1.77 190 13 TGAIVDVPVGEELLGR(53)
EAYPGDVFYLHSR(50)
15 Pyruvate
kinase M2
IPI00847989 49865.9 7.96 41% 0.042 2.81 185 10 LDIDSPPITAR(42)
16 ATP synthase
subunit alpha,
mitochondrial
IPI00440493 59713.6 9.16 26% 0.0048 1.56 183 11 TGAIVDVPVGEELLGR(61)
EAYPGDVFYLHSR(51)
17 Alpha-enolase IPI00465248 47139.3 7.01 35% 0.0033 21.3 264 12 VVIGMDVAASEFFR(64)
AAVPSGASTGIYEALELR(59)
VVIGMDVAASEFFR(41)
18 Cytochrome
b-c1 complex
subunit 1,
mitochondrial
IPI00013847 52612.4 5.94 27% 0.014 1.34 227 10 DVVFNYLHATAFQGT
PLAQAVEGPSENVR(102)
IAEVDASVVR(59)
19 Serpin H1 IPI00032140 46411.2 8.75 28% 0.021 1.51 188 10 LYGPSSVSFADDFVR(71)
DTQSGSLLFIGR(54)
20 Ornithine
aminotransferase,
mitochondrial
IPI00022334 48504.2 6.57 32% 0.038 1.32 206 13 HQVLFIADEIQTGLAR(50)
FAPPLVIKEDELR(48)
21 c-actin IPI00021440 41765.8 5.31 51% 0.015 22.02 263 15 SYELPDGQVITIGNER(54)
QEYDESGPSIVHR(45)
22 c-actin IPI00021440 41765.8 5.31 44% 0.016 21.82 411 12 DLYANTVLSGGTTMYPGIADR(118)
SYELPDGQVITIGNER(92)
IWHHTFYNELR(59) AVFPSIVGRPR(41)
23 c-actin IPI00021440 41765.8 5.31 50% 0.014 21.45 482 14 DLYANTVLSGGTTMYPGIADR(104)
SYELPDGQVITIGNER(79)
TTGIVMDSGDGVTHTV
PIYEGYALPHAILR(63)
IWHHTFYNELR(56)
AGFAGDDAPR(49)
24 c-actin IPI00021440 41765.8 5.31 46% 0.0068 21.34 403 13 DLYANTVLSGGTTMYPGIADR(129)
SYELPDGQVITIGNER(95)
IWHHTFYNELR(55) AVFPSIVGRPR(39)
Differential Proteome Analysis of AIS BM-MSCs
PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18834Since ALP has been considered a valuable indicator for bone
development and differentiation, annexin A2 may alter ALP
activity, thereby facilitating mineralization, a terminal step in the
differentiation process of osteoblastic cells.
In studies of other cell types, there is much evidence to support
the association between annexin A2 and cellular differentiation. For
instance, annexin A2 expression is affected when myeloid cell lines
are induced to differentiate by stimulation with all-trans-retinoic
acid (ATRA) [63].Asdiscussedabove,annexin A2maythereforebe
an important player in cellular differentiation and related disorders.
In this study, we demonstrated that annexin A2 was down-
regulated significantly in MSCs from AIS patients, which was
consistent with the previously described decrease in osteogenic
differentiation ability. It is likely that annexin A2 plays an
important role in osteogenic differentiation of MSCs from AIS
patients and exerts further influence on both intramembrane and
endochondral ossification in AIS. Therefore, annexin A2 might be
responsible, at least in part, for the low bone mass in AIS, although
the exact mechanism in etiology of AIS needs further research.
HSP27
The mammalian small stress protein HSP27 (also denoted
HSP28 and in murine cells, HSP25) belongs to the HSP family
whose synthesis is induced or stimulated by heat shock and other
forms of stress [64]. We would like to discuss HSP27 from the
following two aspects.
(1) HSP27 and Cell Differentiation. Recent studies have
revealed that expression of the small heat shock (or stress) proteins
(sHSP), including that of HSP27, is closely linked to changes in the
state of cell differentiation. During the process of endochondral
bone formation, sHSPs are differentially expressed in a stage-
specific manner [65]. Similar expression of sHSPs was observed
during the differentiation of various mammalian cell types, such as
embryonal carcinoma, embryonic stem cells [66], mouse Ehrlich
ascites tumor cells [67,68], normal B cells, B lymphoma [69],
osteoblasts, promyelocytic leukemia cells [70] and NB4
promyelocytic cells [71].
In addition, transient accumulation of HSP27 has been
observed during phorbol ester-induced monocytic differentiation
of human HL-60 cells [72], as well as during ATRA-induced
granulocytic differentiation of these cells [73].
In this study, HSP27 was down-regulated in MSCs from AIS
patients. Together with the findings of previous studies, HSP27,
as a mediator of cell differentiation, might be related to decreased
differential ability of MSCs and clinical osteopenia in AIS
patients.
Spot
No.
b)
Protein
description
c) IPI No
d) MW
e) PI
f)
Sequence
coverage
g) P value
Average
Ratio
h)
Total
protein
Score
i)
No.of
matched
peptide
(MS)
j) Peptides sequence
k)
25 c-actin IPI00021440 41765.8 5.31 48% 0.027 21.63 339 14 SYELPDGQVITIGNER(82)
DLYANTVLSGGTTMYPGI(77)
IWHHTFYNELR(53)
26 b-actin IPI00894365 39200.5 5.4 24% 0.013 21.46 88 7 SYELPDGQVITIGNER(43)
27 b-actin IPI00894365 39200.5 5.4 27% 0.017 21.4 70 8 SYELPDGQVITIGNER(35)
28 Macrophage-capping
protein
IPI00027341 38493.5 5.88 16% 0.0043 1.51 71 4 QAALQVAEGFISR(57)
29 Annexin A2 IPI00455315 38579.8 7.57 35% 0.038 21.38 80 8 GVDEVTIVNILTNR(46)
30 Elongation factor
1-delta
IPI00023048 31102.8 4.9 39% 0.022 21.38 284 10 SLAGSSGPGASSGTSGDHGELVVR(79)
IASLEVENQSLR(68)
31 Inorganic
pyrophosphatase
IPI00015018 32639.2 5.54 32% 0.041 21.34 140 8 VIAINVDDPDAANYNDINDVKR(68)
32 Annexin A2 IPI00455315 38579.8 7.57 33% 0.03 21.47 103 10 GVDEVTIVNILTNR(62)
36 Heterogeneous
nuclear
ribonucleoprotein K
IPI00514561 47527.6 5.46 28% 0.024 21.31 135 9 LLIHQSLAGGIIGVK(66)
37 Heat shock 27 kDa
protein
IPI00025512 22768.5 5.98 36% 0.022 21.52 163 8 LFDQAFGLPR(61)
LATQSNEITIPVTFESR(40)
39 Glyoxalase I IPI00220766 20764.2 5.12 27% 0.033 1.4 121 7 RFEELGVK(37)
40 Proteasome subunit,
beta type
IPI00789577 12074.3 9.86 57% 0.0062 21.38 68 5 LYIGLAGLATDVQTVAQR(39)
a)Spots for which the volume ratio was $1.3 based on DeCyder software analysis were identified by MALDI-TOF/TOF MS.
b)Spots referring to Figure 3.
c)Protein description: name of each matched protein in IPI human database v3.53 (http://www.ebi.ac. uk/IP/IPIhelp.html) by data searching.
d)IPI No: Protein ID accessed from IPI human database v3.53.
e)MW: theoretical molecular weight of the matched protein in Da.
f)PI: theoretical isoelectric point of the matched protein.
g)Percent of identified sequence to the complete sequence of the known protein.
h)Average volume ratio in AIS group compared to control group.
i)Total protein score based on combined mass and mass/mass spectra.
j)No.of matched peptides: the number of peptides (MS) matched to the candidate protein.
k)All the spots had high-probability results by MASCOT search, and there was at least one peptide analyzed by MS/MS in each spot. Parts of the sequence, determined
by MS/MS, indisputably confirm the peptide.
doi:10.1371/journal.pone.0018834.t002
Table 2. Cont.
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PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e18834Figure 4. Functional classification and subcellular location of identified proteins. Distribution of the identified proteins are presented
according to their (A) biological processes, (B) cellular component, and (C) molecular function. Assignments were made using the GOFACT program
(http://61.50.138.118/gofact) based on Gene Ontology (GO) terms. Prior to the analysis, the differentially regulated proteins were listed as up-
regulated or down-regulated. For example: 57% of the total 34 proteins (or 25 gene products), including 33.3% down-regulated proteins and 23.8%
up-regulated proteins, were involved in the cellular metabolic process.
doi:10.1371/journal.pone.0018834.g004
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tibility. Many etiological studies of AIS suggest that idiopathic
scoliosis is a genetic trait modified by environmental factors. Van
Rhijn et al [74] stated that differences in the development and
progression of scoliosis, as well as age at detection (juvenile vs.
adolescent) may be caused by environmental influences. In
another study, van Rhijn et al [41] noted that only half of twin
pairs showed a difference in lateral Cobb angles of less than 10u,
suggesting that curve severity may be affected by environment. In
addition, Hermus [43] reported a monozygotic twin pair that was
described to be concordant for idiopathic scoliosis, but with
different apical levels, magnitudes, and age at detection, further
stressing the importance of environmental factors. However, the
molecular mechanism of environmental susceptibility in AIS
patients remains unclear.
Both HSP27 and HSP70 have been demonstrated as essential to
ensure proper folding and intracellular localization of newly
synthesized polypeptides [75,76]. The expression of HSPs
(including HSP27 and HSP70), which is activated by unfolded
proteins, can enhance the cell’s capacity not only to prevent
protein aggregation and disassociate such aggregates once formed,
but also to isolate such polypeptides in inclusions and selectively
degrade them [77,78].
Since HSP27 and HSP70 can promote refolding, solubilization,
and degradation of damaged polypeptides, the loss of this
protective response should deteriorate the cell’s capacity to handle
the mutant or damaged proteins. In Parkinson’s disease or
Alzheimer’s disease, for instance, such changes in the cell’s
proteolytic capacity, and the general increase in unfolded
molecules, should further limit the capacity of the cell to deal
with mutant proteins or other abnormal polypeptides and may
thus indirectly contribute to the development of these disorders
[78–80].
Our study showed down-regulation of both HSP27 and HSP70
in MSCs from AIS patients. If these proteins contribute a similar
protective factor in AIS as in the diseases we discussed above, then
its lower expression might subsequently compromise the capacity
of MSCs to cope with aberrant polypeptides or damaged proteins
caused by environmental pathogenic factors of AIS.
Taken together, it is tempting to speculate that the loss of these
protective mechanisms, at least in part, renders AIS patients more
susceptible to environmental factors, and thus eventually leads to
the development and progression of scoliosis. The underlying
mechanism of HSP27 and HSP70 in the etiology of AIS needs
further elucidation.
b-actin and c-actin
b-actin is usually found to be constitutively expressed, with the
expression values often used for normalization of expression data.
Interestingly, in our study, we found significantly decreased b-actin
levels in MSCs from AIS patients.
It has been demonstrated that the actin cytoskeleton, consisting
of both b-actin and c-actin, changes from a large number of thin,
parallel microfilament bundles extending across the entire
cytoplasm in undifferentiated MSCs to a few, thick actin filament
bundles located at the outermost periphery in MSC-differentiated
osteoblasts [81]. Therefore, it is postulated that the actin
cytoskeleton may play a pivotal role in determining the hMSC
mechanical properties and modulation of cellular mechanics
during stem-cell osteodifferentiation [82].
During osteogenic differentiation, it was also observed that
alterations in the cytoskeletal organization affect the expression of
osteogenic differentiation markers, including alkaline phosphatase
activity and calcium deposition [81]. More interestingly, it was
revealed that disrupting actin in hMSCs increased adipogenesis
and decreased osteogenesis when compared to untreated controls,
suggesting that the actin cytoskeleton might be important in the
commitment process [83]. In addition, it was reported that
disruption of the actin cytoskeleton blocks osteoblastic differenti-
ation of cells infected with constitutively active RhoA, which is one
of the key regulators of cytoskeletal contractility [84].
Both b-actin and c-actin were down-regulated in MSCs from
AIS patients in our study, which was in agreement with previous
reports of decreased osteogenic differentiation capacity of MSCs in
AIS patients. Therefore, these data suggest that alteration of the
actin cytoskeleton might be involved in the pathological
mechanism of persistant general osteopenia in AIS. Additionally,
it is worth mentioning that all five identified proteins in our
experiment that were localized in cytoskeleton (b-actin, c-actin,
HSP27, WD repeat-containing protein 1, and moesin) were
differentially down-regulated, indicating that disruption or inhibi-
tion of the cytoskeleton might contribute to the development and
progression of AIS.
Down-regulation of b-actin, HSP27, c-actin, and annexin A2,
and up-regulation of PKM2, was reported for the first time as
associated with the etiology of AIS in this experiment. Further-
more, the expression alterations of these five proteins indicate
increased proliferation ability of MSCs and decreased osteogenic
differentiation ability in AIS, the latter of which was also consistent
with previous studies of AIS-MSC and might be one of
mechanisms causing clinical osteopenia of AIS. In addition, the
discovery of a total of 25 differentially expressed proteins in AIS
patients may provide a valuable basis for further research on the
characteristics of AIS-MSCs as well as the abnormal bone growth
and development in AIS.
In summary, we have described the differential proteome of
BM-MSCs from AIS patients for the first time. Our high-
throughput proteomic approach based on 2D-DIGE technology
followed by MS analysis has produced the differential proteome
profile of BM-MSCs in AIS. A total of 25 proteins were identified
as either up-regulated or down-regulated. These proteins might
be involved in proliferation, differentiation, and other activities of
MSCs. Furthermore, these differentially expressed proteins might
play a significant role, in not only the causal mechanism of
osteopenia in AIS, but also the AIS initiation and development.
The identification of these proteins provides us important
informations in understanding the underlying etiological mech-
anisms of AIS. Further studies are required to clarify the
Figure 5. Validation of five differentially expressed proteins. The figure shows validation of the differential expression of (A) b-actin, (B)
PKM2, (C) HSP27, (D) c-actin, and (E) annexin A2 (ANXA2) by western blot analysis and comparative data (with fold changes and Student’s t test
values) for their corresponding filtered spots by Decyder software. The expression patterns of these proteins show good correlation. Control=control
group; AIS=AIS group. 1) Representative 1-D Western blot analysis of above proteins (all performed on 6 AIS samples and 6 control samples), GAPDH
was used as the internal control. 2) Densitometric analysis of bands from western blot images by ImageQuant software. Values were presented as
relative ratio of differentially expressed protein/GAPDH(y-axis) in MSCs from the control and AIS groups (x-axis), normalized to 1 in control group,
n=6,p,0.05, Student’s t test. Fold changes of the ratio in the AIS group compared to the control group are also presented. 3) Graphic views show
the standardized log abundance of spot volume (y-axis) against the changes of proteins between the AIS and Control groups (x-axis) in all three gels
(with fold changes and Student’s t test values). DeCyder Software 3D view of these 5 differentially expressed protein spots is also shown.
doi:10.1371/journal.pone.0018834.g005
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pathogenesis of AIS.
Supporting Information
Figure S1 The MS and MS/MS spectra of PKM2. The
figure displays the MS spectrum (A) and MS/MS spectrum
marked with b ions and y ions (B) for PKM2 identification. The
sequence of precursor at m/z1197.61 was analyzed by MS/MS to
be LDIDSPPITAR. This protein was identified to be PKM2 after
database searching.
(TIF)
Figure S2 The MS and MS/MS spectra of annexin A2.
The figure displays the MS spectrum (A) and MS/MS spectrum
marked with b ions and y ions (B) for annexin A2 identification.
The sequence of precursor at m/z1542.88 was analyzed by MS/
MS to be GVDEVTIVNILTNR. This protein was identified to be
annexin A2 after database searching.
(TIF)
Figure S3 The MS and MS/MS spectra of b-actin. The
figure displays the MS spectrum (A) and MS/MS spectrum
marked with b ions and y ions (B) for b-actin identification. The
sequence of precursor at m/z1790.97 was analyzed by MS/MS to
be SYELPDGQVITIGNER. This protein was identified to be b-
actin after database searching.
(TIF)
Figure S4 The MS and MS/MS spectra of c-actin. The
figure displays the MS spectrum (A) and two MS/MS spectra
marked with b ions and y ions (B, C) for c-actin identification. The
sequences of precursor at m/z1516.66 and m/z1790.82 were
analyzed by MS/MS to be QEYDESGPSIVHR and
SYELPDGQVITIGNER, respectively. This protein was identified
to be c-actin after database searching.
(TIF)
Figure S5 The MS and MS/MS spectra of HSP27. The
figure displays the MS spectrum (A) and two MS/MS spectra
marked with b ions and y ions (B, C) for HSP27 identification. The
sequences of precursor at m/z1163.58 and m/z1905.92 were
analyzed by MS/MS to be LFDQAFGLPR and LATQSNEI-
TIPVTFESR, respectively. This protein was identified to be
HSP27 after database searching.
(TIF)
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